Pulmatrix Inc (PULM)

US · Healthcare · Biotechnology

$1.43+2.35%

Last close · 2026-09-17

Latest quarter · ended 2026-06-30

Revenue

Net profit

$-1.0M

EPS

$-0.29

Market cap

$5.4M

Forward P/E

0.0

P/B

3.20

Book value

$0.44

EPS (TTM)

$-1.10

52-week high

$5.50

52-week low

$1.16

50-day MA

$1.62

200-day MA

$2.06

Beta

1.90

Analysts rate Pulmatrix Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $10.00.

Insiders

0.78%

Institutions

9.16%

Fund	Stake
Renaissance Technologies Corp	2.99%
BlackRock Inc	1.50%
Geode Capital Management, LLC	1.22%
Vanguard Capital Management, LLC	0.92%
SBI Securities Co Ltd	0.82%
Vanguard Fiduciary Trust Co	0.40%
Jane Street Group LLC	0.40%
State Street Corp	0.38%

Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Pulmatrix Inc — free to start.

Data updated 2026-09-18.